Insider buying
~$50K141K sh @ $0.355
First insider buy since Jun 2025Traded Oct 28 · filed 1 day later
Since the trade −41.2% · S&P 500 −10.7% · to Nov 20
Bought at the 52-week low, RSI 33, 83% under its 200-day average, 71 points behind the S&P 500 over 3 months
The CEO of Actuate Therapeutics paid $50K out of pocket for Actuate Therapeutics shares. It was the first purchase in over a year. Shares held went up 47% with this purchase.